STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] STRYKER CORP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Stryker Corp (SYK) reported an insider stock transaction by its Vice President and Chief Financial Officer. On 11/20/2025, the officer sold 165 shares of Stryker common stock at a price of $365.88 per share, coded as a sale transaction. After this trade, the officer beneficially owned 6,694 shares of common stock directly and an additional 287 shares indirectly through a 401(k) plan. The filing indicates it was submitted by an attorney-in-fact on behalf of the reporting person.

Positive
  • None.
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wells Preston Wendell

(Last) (First) (Middle)
1941 STRYKER WAY

(Street)
PORTAGE MI 49002

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STRYKER CORP [ SYK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/20/2025 S 165 D $365.88 6,694 D
Common Stock 287 I 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Austin Y. Ke, attorney-in-fact for Preston Wendell Wells 11/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Stryker Corp (SYK) report in this Form 4?

The filing reports that the Vice President and Chief Financial Officer of Stryker Corp (SYK) sold 165 shares of common stock on 11/20/2025.

At what price were the Stryker (SYK) shares sold in the reported transaction?

The 165 shares of Stryker common stock were sold at a price of $365.88 per share.

Who is the insider involved in this Stryker (SYK) Form 4 filing and what is their role?

The reporting person is an Officer of Stryker Corp, serving as VP, Chief Financial Officer.

How many Stryker (SYK) shares does the officer own after this transaction?

After the reported sale, the officer beneficially owns 6,694 shares of Stryker common stock directly and 287 shares indirectly through a 401(k) plan.

Is this Stryker (SYK) Form 4 filed by one or multiple reporting persons?

The filing is indicated as a Form filed by One Reporting Person.

Who signed the Stryker (SYK) Form 4 on behalf of the reporting person?

The form was signed by /s/ Austin Y. Ke as attorney-in-fact for Preston Wendell Wells, the reporting person.

Stryker Corp

NYSE:SYK

SYK Rankings

SYK Latest News

SYK Latest SEC Filings

SYK Stock Data

137.86B
361.55M
5.36%
81.68%
1.09%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
PORTAGE